Washington: A fixed-dose combination medication for BP, cholesterol, and platelet control may significantly improve medication adherence after 15 months and small improvements in systolic blood pressure and low-density lipoprotein cholesterol.The randomized trial included about 2,000 patients with or at high risk of cardiovascular disease (CVD).
Health Minister defends AIIMS CVO Chaturvedi`s removal
Clashes betweeen BJP and SP during Nagar Nigam board
Will ensure villages and India`s poor have access to 24-hour electricity: PM
Maharashtra CM Prithviraj Chavan not to share dais with Narendra Modi